HBM Healthcare Investments (Cayman) Ltd. insider trades: Mineralys Therapeutics (MLYS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where HBM Healthcare Investments (Cayman) Ltd. reports to the SEC
and 4 more companies
Open-market buys and sales
53 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 14, 2023 | MLYS | ↑ Buy | 312,500 | $16.00 | $5.0M | Direct | Feb 16, 2023 (2d) |
| Nov 9, 2021 | IOBT | ↑ Buy | 325,000 | $14.00 | $4.5M | Direct | Nov 12, 2021 (3d) |
| Sep 14, 2017 | NBRV | ↓ Sell | 36,608 | $8.56 | $313K | Direct | Sep 14, 2017 (0d) |
| Aug 31, 2017 | NBRV | ↓ Sell | 639 | $9.50 | $6K | Direct | Sep 5, 2017 (5d) |
| Aug 8, 2017 | NBRV | ↓ Sell | 19,803 | $10.50 | $208K | Direct | Aug 9, 2017 (1d) |
| Jul 28, 2017 | NBRV | ↓ Sell | 6,585 | $10.51 | $69K | Direct | Aug 1, 2017 (4d) |
| Jul 24, 2017 | NBRV | ↓ Sell | 160 | $10.50 | $2K | Direct | Jul 26, 2017 (2d) |
| Jul 20, 2017 | NBRV | ↓ Sell | 44,231 | $10.50 | $464K | Direct | Jul 24, 2017 (4d) |
| Jul 20, 2017 | NBRV | ↓ Sell | 44,231 | $10.50 | $464K | Direct | Jul 21, 2017 (1d) |
| Jul 18, 2017 | NBRV | ↓ Sell | 69,854 | $10.51 | $734K | Direct | Jul 18, 2017 (0d) |
| Jul 13, 2017 | NBRV | ↓ Sell | 57,175 | $10.53 | $602K | Direct | Jul 13, 2017 (0d) |
| Jul 7, 2017 | NBRV | ↓ Sell | 2,695 | $10.52 | $28K | Direct | Jul 7, 2017 (0d) |
| Jul 3, 2017 | NBRV | ↓ Sell | 13,127 | $10.94 | $144K | Direct | Jul 5, 2017 (2d) |
| Jun 29, 2017 | NBRV | ↓ Sell | 8,558 | $10.96 | $94K | Direct | Jun 29, 2017 (0d) |
| Jun 1, 2017 | NBRV | ↓ Sell | 400 | $11.27 | $5K | Direct | Jun 5, 2017 (4d) |
| Apr 28, 2017 | NBRV | ↓ Sell | 15,939 | $11.02 | $176K | Direct | Apr 28, 2017 (0d) |
| Apr 21, 2017 | NBRV | ↓ Sell | 2,622 | $11.04 | $29K | Direct | Apr 25, 2017 (4d) |
| Apr 20, 2017 | NBRV | ↓ Sell | 23,932 | $11.11 | $266K | Direct | Apr 20, 2017 (0d) |
| Apr 13, 2017 | NBRV | ↓ Sell | 32,831 | $11.24 | $369K | Direct | Apr 13, 2017 (0d) |
| Apr 10, 2017 | NBRV | ↓ Sell | 90,594 | $10.96 | $993K | Direct | Apr 10, 2017 (0d) |
| May 29, 2015 | PRTK | ↓ Sell | 20,580 | $30.75 | $633K | Direct | Jun 1, 2015 (3d) |
| May 13, 2014 | OPHT | ↓ Sell | 500,000 | $29.75 | $14.9M | Direct | May 15, 2014 (2d) |
| Dec 17, 2013 | PTCT | ↓ Sell | 66,667 | $19.08 | $1.3M | Direct | Dec 19, 2013 (2d) |
| Sep 30, 2013 | OPHT | ↑ Buy | 228,000 | $22.00 | $5.0M | Direct | Oct 3, 2013 (3d) |
| Jun 25, 2013 | PTCT | ↑ Buy | 666,676 | $15.00 | $10.0M | Direct | Jun 28, 2013 (3d) |
| Mar 25, 2013 | PCRX | ↓ Sell10b5-1 | 290,900 | $27.95 | $8.1M | Direct | Mar 25, 2013 (0d) |
| Mar 19, 2013 | PCRX | ↓ Sell10b5-1 | 909,100 | $28.01 | $25.5M | Direct | Mar 21, 2013 (2d) |
| Nov 21, 2011 | PCRX | ↑ Buy | 307,692 | $6.50 | $2.0M | Direct | Nov 22, 2011 (1d) |
| Feb 8, 2011 | PCRX | ↑ Buy | 535,714 | $7.00 | $3.7M | Direct | Feb 10, 2011 (2d) |
| Mar 3, 2010 | MEND | ↓ Sell | 67,396 | $21.09 | $1.4M | Direct | Mar 4, 2010 (1d) |
| Feb 24, 2010 | MEND | ↓ Sell | 70,000 | $19.98 | $1.4M | Direct | Feb 25, 2010 (1d) |
| Feb 22, 2010 | MEND | ↓ Sell | 66,940 | $20.55 | $1.4M | Direct | Feb 23, 2010 (1d) |
| Aug 13, 2009 | MEND | ↓ Sell | 25,000 | $11.01 | $275K | Direct | Aug 17, 2009 (4d) |
| Aug 12, 2009 | MEND | ↓ Sell | 50,000 | $11.03 | $552K | Direct | Aug 13, 2009 (1d) |
| Aug 11, 2009 | MEND | ↓ Sell | 46,100 | $10.94 | $504K | Direct | Aug 12, 2009 (1d) |
| Aug 10, 2009 | MEND | ↓ Sell | 21,100 | $11.04 | $233K | Direct | Aug 12, 2009 (2d) |
| Aug 7, 2009 | MEND | ↓ Sell | 25,000 | $10.95 | $274K | Direct | Aug 11, 2009 (4d) |
| Jun 20, 2008 | MEND | ↑ Buy | 17,741 | $13.76 | $244K | Direct | Jun 23, 2008 (3d) |
| Jun 19, 2008 | MEND | ↑ Buy | 3,459 | $13.59 | $47K | Direct | Jun 20, 2008 (1d) |
| Jun 17, 2008 | MEND | ↑ Buy | 3,800 | $13.58 | $52K | Direct | Jun 19, 2008 (2d) |
| Jun 6, 2008 | MEND | ↑ Buy | 45,000 | $12.12 | $545K | Direct | Jun 10, 2008 (4d) |
| Feb 15, 2008 | MEND | ↑ Buy | 7,700 | $13.98 | $108K | Direct | Feb 19, 2008 (4d) |
| Feb 14, 2008 | MEND | ↑ Buy | 25,800 | $14.19 | $366K | Direct | Feb 14, 2008 (0d) |
| Feb 14, 2008 | MEND | ↑ Buy | 22,800 | $14.30 | $326K | Direct | Feb 14, 2008 (0d) |
| Feb 13, 2008 | MEND | ↑ Buy | 50,100 | $14.56 | $729K | Direct | Feb 14, 2008 (1d) |
| Feb 13, 2008 | MEND | ↑ Buy | 40,200 | $14.74 | $593K | Direct | Feb 14, 2008 (1d) |
| Feb 12, 2008 | MEND | ↑ Buy | 29,900 | $14.61 | $437K | Direct | Feb 14, 2008 (2d) |
| Aug 22, 2007 | MEND | ↓ Sell | 1,100 | $23.28 | $26K | Direct | Aug 24, 2007 (2d) |
| Aug 21, 2007 | [MEND] | ↓ Sell | 10,900 | $23.21 | $253K | Direct | Aug 21, 2007 (0d) |
| Aug 21, 2007 | MEND | ↓ Sell | 1,635 | $23.28 | $38K | Direct | Aug 21, 2007 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MLYS insiders
Open-market trades in the last 12 months
About HBM Healthcare Investments (Cayman) Ltd.'s insider trades
HBM Healthcare Investments (Cayman) Ltd. is a 10% owner of Mineralys Therapeutics (MLYS). Since Feb 9, 2007, it has reported 16 open-market purchases worth $33.8M and 37 sales worth $65.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
2 sales (51% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Its filings also include conversions (7 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MLYS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.